Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer and film

ABSTRACT

A polymerizable liquid crystal compound represented by formula (I) is disclosed. R 0  and R 1  represent a hydrogen atom, or C 1-4  alkyl; L 0  and L 1  represent a hydrogen atom, or C 1-4  alkyl group; A 0  and A 1  represent a divalent linking group having a 5- to 12-membered cyclic structure; B 0  and B 1  represent a single bond or a divalent linking group having a 5- to 12-membered cyclic structure; D 0  and D 1  represent —O—, —S—, or —NR 2 —; X 0  and X 1  represent a hydrogen atom, acyl group or cyano; Y 0  and Y 1  represent a single bond or a divalent group; Q 0  and Q 1  represent a C 1-20  divalent aliphatic group; Z 0  and Z 1  represent a hydrogen atom, cyano, halogen atom or polymerizable group; and n and m each independently represent an integer of from 0 to 2.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit of priority from Japanese Patent Application No. 2010-074758, filed on Mar. 29, 2010, the contents of which are herein incorporated by reference in their entirety.

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to a polymerizable liquid crystal compound, polymerizable liquid crystal composition and polymer useful in various applications such as optical members of which examples include optically anisotropic films and heat-shielding films, and also relates to films employing these.

2. Background Art

Previously, polymerizable liquid crystal compounds have been used as a material of optical films. For example, there has been provided optical compensation films for liquid crystal displaying devices employing the alignment of liquid crystal compound and reflective films employing cholesteric liquid crystal. Azine-derivatives have been provided as a polymerizable liquid crystal compound (JP-A-2008-291218, JP-A-2009-167378, WO2008/102838, JP-A-2009-223189, JP-A-10-147562). Especially, in JP-A-2008-291218 or JP-A-2009-167378, azine-derivatives, exhibiting high birefringence, are disclosed.

SUMMARY OF THE INVENTION

However, recently, the demands for liquid crystal materials, exhibiting higher Δn, more and more increase. And they may be required to show good compatibility with another liquid crystal material when they are used in various applications.

One object of the invention is to provide a novel polymerizable liquid crystal compound showing high Δn and good compatibility with another liquid crystal material.

Another object of the invention is to provide a polymerizable liquid crystal composition and polymer, employing the polymerizable liquid crystal compound, useful in various applications

Another object of the invention is to provide a film, employing the polymerizable liquid crystal compound, useful in various applications

The means for achieving the objects are as follows.

[1] A polymerizable liquid crystal compound represented by formula (I):

where R⁰ and R¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent; L⁰ and L¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent; A⁰ and A¹ each independently represent a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent; B⁰ and B¹ each independently represent a single bond or a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent; D⁰ and D¹ each independently represent —O—, —S—, or —NR²— where R² represents a hydrogen atom or C₁₋₃ alkyl group; X⁰ and X¹ each independently represent a hydrogen atom, acyl group or cyano; Y⁰ and Y¹ each independently represent a single bond, —O—, —S—, —OCO—, —COO—, —OCOO—, —NR³CO—, —CONR³—, —OCONR³—, —NR³COO—, —NR³CONR³—, —C═N— or —N═C— where R³ represents a hydrogen atom or C₁₋₃ alkyl group; Q⁰ and Q¹ each independently represent a C₁₋₂₀ divalent aliphatic group which may have at least one substituent; provided that one —CH₂— or two or more —CH₂—, which may be not adjacent to each other, may be replaced with —O—, —S—, —NR⁴—, —OCO—, —COO—, —OCOO—, —NR⁴CO—, or —CONR⁴—; R⁴ represents a hydrogen atom or C₁₋₃ alkyl group; Z⁰ and Z¹ each independently represent a hydrogen atom, cyano, halogen atom or polymerizable group; and n and m each independently represent an integer of from 0 to 2.

[2] The polymerizable liquid crystal compound of [1], wherein A⁰ and A¹ each independently represent a divalent aromatic group which may have at least one substituent.

[3] The polymerizable liquid crystal compound of [1] or [2], wherein B⁰ and B¹ each independently represent a divalent aromatic group which may have at least one substituent.

[4] The polymerizable liquid crystal compound of any one of [1]-[3], wherein at least one of Z⁰ and Z¹ represents a polymerizable group selected from Group (II) shown below:

[5] The polymerizable liquid crystal compound of [4], wherein Z⁰ and Z¹ each independently represent a polymerizable group selected from Group (II). [6] The polymerizable liquid crystal compound of any one of [1]-[5], wherein Z⁰ and Z¹ each independently represent a (meth)acrylate group. [7] The polymerizable liquid crystal compound of any one of [1]-[6], wherein n and m are 1. [8] The polymerizable liquid crystal compound of any one of [1]-[7], wherein D⁰ and D¹ are —O—. [9] The polymerizable liquid crystal compound of any one of [1]-[8], wherein L⁰ and L¹ are hydrogen atoms. [10] The polymerizable liquid crystal compound of any one of [1]-[9], wherein X⁰ and X¹ are same, and represent a hydrogen atom or cyano. [11] The polymerizable liquid crystal compound of any one of [1]-[10], wherein Y⁰ and Y¹ are —O—. [12] The polymerizable liquid crystal compound of any one of [1]-[11], wherein at least one of R⁰ and R¹ is not a hydrogen atom. [13] A polymerizable liquid crystal composition comprising at least one polymerizable liquid crystal compound of any one of [1]-[12]. [14] The polymerizable liquid crystal composition of any one of [13], comprising at least one chiral compound. [15] A polymer prepared by polymerizing a polymerizable liquid crystal compound of any one of [1]-[12] or a polymerizable liquid crystal composition of [13] or [14]. [16] A film formed by curing a polymerizable liquid crystal composition of [13] or [14]. [17] A film formed by curing a cholesteric liquid crystal phase of a polymerizable liquid crystal composition of [14]. [18] The film of [16] or [17], having optical anisotropy. [19] The film of any one of [16]-[18], having selective reflection. [20] The film of [19], having selective reflection in the infrared region.

According to the invention, it is possible to provide a novel polymerizable liquid crystal compound showing high Δn and good compatibility with another liquid crystal material.

According to the invention, it is to provide a polymerizable liquid crystal composition and polymer, employing the polymerizable liquid crystal compound, useful in various applications

According to the invention, it is possible to provide a film, employing the polymerizable liquid crystal compound, useful in various applications

DETAILED DESCRIPTION OF THE INVENTION

The present invention will be detailed below. In this description, the numerical range expressed by the wording “a number to another number” means the range that falls between the former number indicating the lowermost limit of the range and the latter number indicating the uppermost limit thereof.

1. Polymerizable Liquid Crystal Compound

The present invention relates to a polymerizable liquid crystal compound represented by formula (I). The compound of the invention shows higher Δn compared with the known azine-derivative. The compound of the invention shows also good compatibility with another liquid crystal material, is polymerizable, and is useful in various applications such as optical members.

In the formula, R⁰ and R¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent. Examples of the alkyl group include methyl, ethyl, n- and iso-propyl, and n-, iso- and tert-butyl. The alkyl group may have at least one substituent, and examples of the substituent include halogen atoms such as fluorine, chlorine and bromine atoms, and C₁₋₅ alkyloxy carbonyl group.

Preferably, at least one of R⁰ and R¹ represent a C₁₋₄ alkyl group which may have at least one substituent, or more preferably, a non-substituted C₁₋₄ alkyl group. Or preferably, both of them represent a non-substituted alkyl group.

In the formula, L⁰ and L¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent. Examples of the alkyl group represented by L⁰ or L¹ are same as those exemplified for R¹ or R⁰, and examples of its substituent are also same as those exemplified for R¹ or R⁰

Preferably, both of L⁰ and L¹ are hydrogen atoms.

In the formula, A⁰ and A¹ each independently represent a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent. The cyclic structure may be a monocyclic structure or condensed ring structure. The monocyclic structure is preferably a 5- to 7-membered cyclic structure, or more preferably, a 5- or 6-membered cyclic structure. The cyclic structure may be an aromatic or aliphatic cyclic structure. Or the cyclic structure may be a hetero cyclic structure in which at least one hetero atom selected from nitrogen, oxygen and sulfur atoms is embedded. Examples of the cyclic structure include benzene, naphthalene, cyclohexane, pyridine, thiophene, furan, pyrrole, pyrazine, pyrimidine and pyridazine rings. A⁰ and A¹ may have two or more cyclic structures, and in such a case, the cyclic structures may be linked by a single bond or a divalent group. Examples of the divalent group include ethenyl, ethynyl and azo.

Examples of A⁰ or A¹ include but are not limited to, those shown below.

Preferably, A⁰ and A¹ each independently represent a divalent group having at least one aromatic ring which may have at least one substituent, or more preferably, a divalent group having at least one benzene, naphthalene, or pyridine ring which may have at least one substituent. Among these, the divalent group of a benzene ring which may have at least one substituent is especially preferable.

The cyclic structure may have at least one substituent. Examples of the substituent include C₁₋₄ alkyls, C₁₋₄ alkoxys, halogen atoms, hydroxy, C₂₋₅ alkoxycarbonyls, and C₂₋₅ alkylcarbonyloxys. Among these, C₁₋₄ alkoxys and halogen atoms are preferable; and C₁₋₄ alkoxys are more preferable. In the examples having a benzene ring as the cyclic structure, the substituent preferably binds to the meta-position with respect to the azine group.

In the formula, B⁰ and B¹ each independently represent a single bond or a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent. Preferably, B⁰ and B¹ each independently represent a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent. The cyclic structure may be a monocyclic structure or condensed ring structure. The monocyclic structure is preferably a 5- to 7-membered cyclic structure, or more preferably, a 5- or 6-membered cyclic structure. The cyclic structure may be an aromatic or aliphatic cyclic structure. Or the cyclic structure may be a hetero cyclic structure in which at least one hetero atom selected from nitrogen, oxygen and sulfur atoms is embedded. Examples of the cyclic structure include benzene, naphthalene, cyclohexane, pyridine, thiophene, furan, pyrrole, pyrazine, pyrimidine and pyridazine rings. B⁰ and B¹ may have two or more cyclic structures, and in such a case, the cyclic structures may be linked by a single bond or a divalent group. Examples of the divalent group include ethenyl, ethynyl and azo.

Preferably, B⁰ and B¹ each independently represent a divalent group having at least one aromatic ring which may have at least one substituent, or more preferably, a divalent group having at least one benzene, naphthalene, or pyridine ring which may have at least one substituent. Among these, the divalent group of a non-substituted benzene ring is especially preferable.

B⁰ and B¹ may have at least one substituent. Examples of the substituent are same as those exemplified for the substituent which the cyclic structure of A⁰ or A¹ may have.

In the formula, n and m each independently represent an integer of from 0 to 2, or preferably 0 or 1.

In the formula, D⁰ and D¹ each independently represent —O—, —S—, or —NR²— where R² represents a hydrogen atom or C₁₋₃ alkyl group such as methyl, ethyl and n- and iso-propyl.

The compounds of the invention, having any selected from the above-described divalent group as D⁰ or D¹, may have high Δn. Preferably, both of D⁰ and D¹ are —O—.

In the formula, X⁰ and X¹ each independently represent a hydrogen atom, acyl group or cyano. Preferably, X⁰ and X¹ are same. Preferably, X⁰ and X¹ each independently represent a hydrogen atom or cyano. More preferably, X⁰ and X¹ are same and represent a hydrogen atom or cyano.

In the formula, Y⁰ and Y¹ each independently represent a single bond, —O—, —S—, —OCO—, —COO—, —OCOO—, —NR³CO—, —CONR³—, —OCONR³—, —NR³COO—, —NR³CONR³—, —C═N— or —N═C— where R³ represents a hydrogen atom or C₁₋₃ alkyl group such as methyl, ethyl or n- and iso-propyl. Preferably, Y⁰ and Y¹ each independently represent a single bond, —O—, —S—, —OCO—, —COO— or —OCOO—. More preferably, Y⁰ and Y¹ each independently represent —O—, —OCO—, —COO— or —OCOO—; or especially preferably, Y⁰ and Y¹ each independently represent —O—.

The compounds of the invention, having any selected from the above-described divalent group as Y⁰ or Y¹, may have high Δn. Preferably, both of Y⁰ and Y¹ are —O—.

In the formula, Q⁰ and Q¹ each independently represent a C₁₋₂₀ divalent aliphatic group which may have at least one substituent; provided that one —CH₂— or two or more —CH₂—, which may be not adjacent to each other, may be replaced with —O—, —S—, —NR⁴—, —OCO—, —COO—, —OCOO—, —NR⁴CO—, or —CONR⁴—; R⁴ represents a hydrogen atom or C₁₋₃ alkyl group such as methyl, ethyl or n- and iso-propyl. The C₁₋₂₀ divalent aliphatic group is preferably a C₁₋₂₀ (more preferably C₂₋₁₀, or even more preferably C₂₋₆) alkylene group, or C₂₋₂₀ (more preferably C₂₋₁₀, or even more preferably C₂₋₆) alkenylene group.

Examples of —Y⁰-Q⁰- or —Y¹-Q¹ include —COO—(CH₂)_(q)—O—, —OCO—(CH₂)_(q)—O—, —NHCO—(CH₂)_(q)—O—, —CONH—(CH₂)_(q)—O—, —O—(CH₂)_(q)—O—, —COO—(CH_(2r+1)O)_(q)—O—, —OCO—(CH_(2r+1)O)_(q)—O—, —NHCO—(CH_(2r+1)O)_(q)—O—, —CONH—(CH_(2r+1)O)_(q)—O—, and —O—(CH_(2r+1)O)_(q)—O—. In the formulas, q is an integer of from 1 to 10, and r is an integer of from 1 to 4.

In the formula, Z⁰ and Z¹ each independently represent a hydrogen atom, cyano, halogen atom or polymerizable group. Examples of the polymerizable group include any functional groups capable of carrying out addition polymerization or condensation polymerization. Examples of the polymerizable group include those shown below.

The functional groups capable of carrying out addition polymerization are especially preferable. Among such polymerizable groups, ethylenic unsaturated polymerizable groups and ring-opening polymerizable groups are preferable.

The polymerizable group is preferably selected from Group (II) shown below.

Among these, (meth)acrylate groups are preferable. Or, that is, the groups shown below are preferable.

In the formula, preferably, at least on of Z⁰ and Z¹ is a polymerizable group, or more preferably, both of Z⁰ and Z¹ are polymerizable groups. Even more preferably, Z⁰ and Z¹ each independently represent a polymerizable group selected from Group (II) described above. Or even more preferably, Z⁰ and Z¹ represent a (meth)acrylate group.

Examples of —Y⁰-Q⁰-Z⁰ or —Y¹-Q¹-Z¹ include, but are not limited to, those shown below.

Preferable examples of the compound represented by formula (I) include the compounds represented by formula (Ia) shown below.

The definitions of the symbols in formula (Ia) are same as those in formula (I) respectively, and their preferable examples are also same as those in formula (I). Each of R represents a substituent, and examples of the substituent represented by R are same as those of the substituent which A⁰, A¹, B⁰ and B¹ in formula (I) may have. In the formula, each of p is an integer of from 0 to 4.

The compound represented by formula (I) may have a symmetric or asymmetric structure with respect to the azine group, ═N—N═, as a center. The symmetric compounds may be prepared more easily with a lower cost and tend to show a higher transition temperature to the isotropic phase, compared with the asymmetric compounds.

In formula (I), L⁰, L¹, X⁰ and X¹ function as a lateral substituent in a liquid crystal molecule. There is the description about the lateral substituent in “Liquid Crystal Handbook (EKISHO BINRAN)” published by MARUZEN, p. 274. Introducing the lateral substituent into liquid crystal molecules may contribute to lowering the transition temperature (melting point) from the crystal phase to the liquid crystal phase and the transition temperature (NI point) from the liquid crystal phase to the liquid phase; and as a result, it may contribute to shifting the temperature range of the liquid crystal phase to the lower range. However, introducing the larger lateral substituent may lower the NI temperature remarkably, and the temperature range of the liquid crystal phase may become narrower. Therefore, preferably, the substituent has an appropriate dimension, and more specifically, the length of the substituent is preferably C₄ or shorter.

The compounds having an electron-attracting group as X⁰ or X¹ may show absorption along the direction of the molecular long axis at a longer wavelength, and so may contribute to increasing Δn. However, if X⁰ or X¹ has a large substituent, the liquid crystallinity may be lowered by the above-described effect of the lateral substituent, and Δn may be lowered. From the above-described point of view, preferably, X⁰ or X¹ exhibits an electron-attracting property, and is an acyl or cyano.

Examples of the compound represented by formula (I) include, but are not limited to, those shown below.

The compound represented by formula (I) may be prepared by combining any organic synthetic reactions. One example is as follows. An intermediate of an azine-derivative represented by formula (III) shown below is prepared, and then, is reacted with a cinnamic acid derivative to give a compound represented by formula (I).

The definitions of the symbols in formula (III) are same as those in formula (I) respectively; and G¹ and G⁰ respectively represent a reaction group such as amino, hydroxy, mercapto and carboxyl.

The intermediate of the azine-derivative may be synthesized by referring to Journal of the American Chemical Society, 1946, p. 1983.

The symmetric azine-compound may be prepared by mixing hydrazine and two equivalents of aldehyde compound in any solvent at a room temperature. Or the asymmetric azine-compound may be prepared by carrying out the reaction of hydrazine with two equivalents of ketone compound in the presence of any acetic acid catalyst in any solvent under heat.

The asymmetric azine-compound may be synthesized by referring to Journal of the American Chemical Society, 1946, p. 1983.

More specifically, a corresponding hydrazone compound may be prepared by using an excessive amount of hydrazine and a ketone compound, and then be reacted with another ketone compound or aldehyde compound to give the asymmetric azine-compound.

Furthermore, the synthesis of the intermediate, the azine-compound, can be carried out even if the ketone or aldehyde compound has at least one substituent (for example, an alkyl, alkoxy, halogen atom, amino, hydroxy, mercapto, carboxyl, oxycarboxyl, carbonyloxy, amide).

If necessary, the yield of the azine-compound may be improved by inactivating the reaction group (for example, amino, hydroxy, mercapto, carboxyl) with a protective group.

The cinnamic acid derivative to be reacted with the intermediate, the azine-derivative, may be prepared according to any method. For example, the cinnamic acid derivative may be prepared by referring to Japanese Patent No. 4355406. More specifically, the cinnamic acid derivative may be prepared by carrying out dehydration-condensation of a carbonyl compound and a carboxylic acid, having an activated methylene, or its derivative in the presence of basic catalyst. The carbonyl compound may be selected from aromatic aldehydes or aromatic ketones. The carboxylic acid having an activated methylene may be selected from malonic acid, acetoacetic esters, or cyano acetic acid.

The polymerizable liquid crystal compound of the invention may be prepared by combining the known processes (for example, described in “Synthetic Methods of Organic Compounds in each functional group [I], [II]” written by Sandra, Caro, published by Hirokawa Publishing INC. in 1976) of forming any chemical bonding such as —O—, —S—, —NH—C(═O)—, —C(═O)NH—, —NHC(═O)NH—, —O—C(═O)— and —C(═O)—O—.

The polymerizable liquid crystal compound of the invention may be prepared typically by reacting the azine intermediate with a cinnamic acid derivative according to any combination of the reactions of forming any chemical bond such as an ether bond (—O—), ester bond (—C(═O)—O—), amide bond (—C(═O)NH—), mixed acid anhydride (—COOSO₂R or —COOCOR) and acid chloride (—COCl). The polymerizable liquid crystal compound may be prepared, if necessary, by further modification.

The formation of an ether bond may be carried out as follows.

-   (i) A compound represented by formula of Q¹-X (X represents a     halogen atom), and a compound represented by formula of Q²-OM (M     represents an alkali metal, mainly sodium) are mixed, and then are     reacted by condensation. In the formulas, Q¹ and Q² each     independently represent an organic group B (the same applies to the     followings). This reaction is generally called as Williamson     synthesis. -   (ii) A compound represented by formula of Q¹-X (X represents a     halogen atom), and a compound represented by formula of Q²-OH are     mixed, and then are condensation-reacted in the presence of a base     such as sodium hydroxide and potassium hydroxide. -   (iii) A compound represented by formula of Q¹-E (E represents an     epoxy group9, and a compound represented by formula of Q²-OH are     mixed, and then are condensation-reacted in the presence of a base     such as sodium hydroxide and potassium hydroxide. -   (iv) A compound represented by formula of Q¹-OFN (“OFN” represents a     group having an unsaturated bond), and a compound represented by     formula of Q²-OM (M represents an alkali metal, mainly sodium) are     mixed, and then are addition-reacted in the presence of a base such     as sodium hydroxide and potassium hydroxide. -   (v) A compound represented by formula Q¹-X (X represents a halogen     atom), a compound represented by formula of Q²-OM (M represents an     alkali metal, mainly sodium) are mixed, and are condensation-reacted     in the presence of copper or cuprous chloride. This reaction is     called as Ullmann condensation.

The formation of an ester or amide bond may be carried out as follows.

-   (i) A compound represented by formula of Q¹-COOH, and a compound     represented by formula of Q²-OH or Q²-NH₂ are     dehydration-condensation-reacted in the presence of an agent of     dehydration-condensation (for example, N—N-dicyclohexyl     carbodiimide). -   (ii) A compound by formula of Q¹-COOH is reacted with a halogenating     agent to give a compound represented by formula of Q¹-COX (X     represents a halogen atom); and then the compound represented by     formula of Q¹-COX is reacted with a compound represented by formula     of Q²-OH or Q²-NH₂ in the presence of a base. -   (iii) A compound represented by formula of Q¹-COOH is reacted with     acid anhydrite or acid chloride to give a mixed acid anhydride; and     then the mixed acid anhydride is reacted with a compound represented     by formula of Q²-OH or Q²-NH₂. -   (iv) A compound represented by formula of Q¹-COOH, and a compound     represented by formula of Q²-OH or Q²-NH₂ are     dehydration-condensation-reacted in the presence of acid- or     base-catalyst.

The formation of an acid chloride may be carried out as follows.

-   (i) A compound represented by formula of Q¹-COOH is reacted with     phosphorus trichloride or phosphorus pentachloride. -   (ii) A compound represented by formula of Q¹-COOH is reacted with     thionyl chloride. -   (iii) A compound represented by formula of Q¹-COOH is reacted with     oxalyl chloride. -   (iv) A compound represented by formula of Q¹-COOAg (Ag represents a     silver) is reacted with chlorine or bromine. -   (v) A compound represented by formula of Q¹-COOH is reacted with a     carbon tetrachloride solution of red mercuric oxide.

In the synthesis of some of the polymerizable liquid crystal compound of the invention, the yield may be improved by protecting hydroxide(s) in the intermediate. Examples of the process for protecting hydroxide(s) include the processes described in “Greene's Protective Groups in Organic Synthesis”, third edition, published by Wiley-Interscience, in 1999.

The protection of hydroxide may be carried out as follows.

-   (i) A compound represented by formula of Q¹Q²Q³-Si—X (X represents a     halogen atom. the same is applied to the followings), and a compound     represented by formula of Q⁴-OH are reacted in the presence of a     base such as imidazole or pyridine. In the formula, Q¹ to Q⁴ each     independently represent an organic group B (the same is applied to     the followings). -   (ii) A vinyl ether such as 3,4-dihydro-2H-pyrane, and a compound     represented by formula of Q²-OH are reacted in the presence of an     acid such as para-toluene sulfonic acid, pyridine para-toluene     sulfonate, and hydrochloric acid. -   (iii) A compound represented by formula of Q¹-C(C═O)—X and a     compound represented by formula of Q⁴-OH are reacted in the presence     of a base such as triethylamine and pyridine. -   (iv) An acid anhydride represented by formula of     Q¹-C(C═O)—O—C(C═O)-Q², and a compound represented by formula of     Q³-OH are reacted, if necessary, in the presence of a base such as     sodium hydroxide and triethylamine. -   (v) A compound represented by formula of Q¹-X and a compound     represented by formula of Q²-OH are reacted in the presence of a     base such as sodium hydroxide and triethylamine. -   (vi) A compound represented by formula of Q¹-O—CH₂—X, and a compound     represented by formula of Q²-OH are reacted in the presence of a     base such as sodium hydride, sodium hydroxide, triethylamine and     pyridine. -   (vii) A compound represented by formula of Q¹-O—CH₂—C(C═O)—X, and a     compound represented by formula of Q⁴-OH are reacted in the presence     of a base such as potassium carbonate and sodium hydroxide. -   (viii) A compound represented by formula of Q¹-O—C(C═O)—X, and a     compound represented by formula of Q²-OH are reacted in the presence     of a base such as triethylamine and pyridine.

The deprotection of the protection group for hydroxide may be carried out according to any known method as follows.

-   (i) The deprotection may be carried out by addition of fluorine ion     such as tetrabutyl ammonium fluoride. -   (ii) The deprotection may be carried out by addition of an acid such     as para-toluenesulfonic acid, pyridine para-toluene sulfonate,     hydrochloric acid, and acetic acid. -   (iii) The deprotection may be carried out by addition of a base such     as sodium hydride, sodium hydroxide, potassium hydroxide, sodium     carbonate, potassium carbonate, triethylamine and pyridine. -   (iv) The deprotection may be carried out in the presence of Pd—C     catalyst or the like by addition of hydrogen.

These processes may be selected depending on the structure or type of the protection group.

In any method, at the termination of reaction, any usual post-treatment in the technical field of organic synthetic chemistry may be carried out. The target compound may be isolated, if necessary, by carrying out any known separation or purification treatment such as column chromatography, recrystallization or distillation.

The determination of the target compound may be performed by measurement of NMR spectra, IR spectra or mass spectra, or elemental analysis.

The polymerizable liquid crystal compound of the invention shows high Δn, and the film of the cured alignment of the compound may achieve the desired optical properties with a thinner thickness, compared with the film of the cured alignment of a liquid crystal compound having low Δn.

2. Polymerizable Liquid Crystal Composition and Film

The present invention relates to a polymerizable liquid crystal composition containing at least one compound represented by formula (I), and to a film formed of the composition. The composition of the invention is useful as a material for optical films such as retardation films and reflective films.

One embodiment of the polymerizable liquid crystal composition of the invention contains at least one compound represented by formula (I) and at least one chiral compound. The film, which is formed by curing the cholesteric liquid crystal alignment of the embodiment, may exhibit selective reflection ascribed to the helical pitch, which is useful as a reflective film (for example, IR reflective film). By using the polymerizable liquid crystal compound showing high Δn, the film having a thickness may exhibit reflection for the broader wavelength region, compared with a film having the same thickness prepared by using a liquid crystal compound showing low Δn.

In the composition of the invention, the compound represented by formula (I) may be a major ingredient or additive. An amount of the compound represented by formula (I) is preferably equal to or more than 5 mass % with respect to the total mass of the composition in terms of obtaining the effect of the compound, more preferably is equal to or more than 10 mass %, even more, preferably is equal to or more than 15 mass %, or even much more preferably is equal to or more than 20 mass %. However, an amount of the compound of the invention in the composition is not limited.

(1) Chiral Compound

For preparing the liquid crystal composition of the invention capable of forming a cholesteric liquid crystal phase, preferably, at least one chiral compound may be added to the composition. The chiral compound may be selected from liquid crystal compounds or non-liquid crystal compounds. The chiral compound may be selected from any known chiral agents such as those used in twisted-nematic (TN) and super-twisted-nematic (STN) modes, which are described, for example, in “Ekisho Debaisu Handobukku (Liquid Crystal Device Handbook)”, Third Chapter, 4-3 Chapter, p. 199, edited by No. 142 Committee of Japan Society for the Promotion of Science, published by the Nikkan Kogyo Shimbun, Ltd., in 1989. Although, generally, a chiral compound has a chiral carbon in its molecule, axially chiral compounds and planar chiral compound, having no chiral carbon, may be used as a chiral compound in the invention. Examples of the axially chiral compound or the planar chiral compound include binaphthyl, helicene, paracyclophane and derivatives thereof. The chiral compound (chiral agent) may have at least one polymerizable group. Using a polymerizable chiral compound along with a polymerizable rod-like compound, it is possible to obtain a polymer having repeating units derived from the optically-active compound and the rod-like liquid crystal compound respectively by carrying out the polymerization thereof. In such an embodiment, the polymerizable group in the chiral compound is preferably same as that in the rod-like liquid crystal compound. Accordingly, the polymerizable group in the optically-active compound is preferably selected from an unsaturated polymerizable group, epoxy group and aziridinyl group; and an unsaturated polymerizable group is preferable; and an ethylene unsaturated polymerizable group is especially preferable.

An amount of the chiral compound is preferably from 1 to 30% by mole with respect to an amount of the liquid crystal compound represented by formula (I) used along with it. A smaller amount of the chiral compound is more preferable since influence thereof on liquid crystallinity may be small. Accordingly, chiral compounds having a strong helical twisting power are preferable since they may achieve the desired helical pitch by being added in a small amount. Examples of such a chiral compound having a strong helical twisting power include those described in JPA 2003-287623.

(2) Other Liquid Crystal Compounds

The composition of the invention may contain at least one liquid crystal compound other than formula (I) along with the compound of formula (I). The compound represented by formula (I) exhibits high compatibility with another liquid crystal compound, may not become opacified even if being mixed with other liquid crystal compound(s), and may form a transparent film. According to the invention, the composition may contain other liquid crystal compound(s) along with the compound represented by formula (I), and may be used in various applications. Examples of other liquid crystal compound which can be used along with the compound represented by formula (I) include azomethines, azoxys, cyanobiphenyls, cyanophenyl esters, benzoic acid esters, cyclohexanecarboxylic acid phenyl esters, cyanophenylcyclohexanes, cyano-substituted phenylpyrimidines, alkoxy-substituted phenylpyrimidines, phenyl dioxanes, tolans and alkenylcyclohexyl benzonitriles. In the invention, the liquid crystal compound can be selected from not only low-molecular weight compounds but also high-molecular weight compounds.

Other liquid crystal compound which can be used along with the compound represented by formula (I) may be polymerizable or not polymerizable. Examples of the rod-like liquid crystal having no polymerizable group are described in many documents such as Y. Goto et. al., Mol. Cryst. Liq. Cryst. 1995, Vol. 260, pp. 23-28.

A polymerizable rod-like liquid crystal compound may be prepared by introducing a polymerizable group in rod-liquid crystal compound. Examples of the polymerizable group include an unsaturated polymerizable group, epoxy group, and aziridinyl group; and an unsaturated polymerizable group is preferable; and an ethylene unsaturated polymerizable group is especially preferable. The polymerizable group may be introduced in a rod-like liquid crystal compound according to any method. The number of the polymerizable group in the polymerizable rod-like liquid crystal compound is preferably from 1 to 6 and more preferably from 1 to 3. Examples of the polymerizable rod-like liquid crystal compound include those described in Makromol. Chem., vol. 190, p. 2255 (1989), Advanced Materials, vol. 5, p. 107 (1993), U.S. Pat. No. 4,683,327, U.S. Pat. No. 5,622,648, U.S. Pat. No. 5,770,107, WO95/22586, WO95/24455, WO97/00600, WO98/23580, WO98/52905, JPA No. 1-272551, JPA No. 6-16616, JPA No. 7-110469, JPA No. 11-80081 and JPA No. 2001-328973. Plural types of polymerizable rod-like liquid crystal compounds may be used in combination. Using plural types of polymerizable rod-like liquid crystal compounds may contribute to lowering the alignment temperature.

An amount of other liquid crystal compound(s) is not limited. Any embodiments, in which an amount of the liquid crystal compound represented by formula (I) is higher or smaller than or same as that of other liquid crystal compound(s), may be prepared depending on their applications.

(3) Polymerization Initiator

The composition of the invention preferably contains at least one polymerization initiator. According to the invention, the polymerization may be carried out under irradiation of ultraviolet light, and the polymerization initiator is preferably selected from photo-polymerization initiators capable of initiating polymerizations by irradiation of ultraviolet light. Examples of the photo-polymerization initiator include α-carbonyl compounds (those described in U.S. Pat. Nos. 2,367,661 and 2,367,670), acyloin ethers (those described in U.S. Pat. No. 2,448,828), α-hydrocarbon-substituted aromatic acyloin compounds (those described in U.S. Pat. No. 2,722,512), polynuclear quinone compounds (those described in U.S. Pat. Nos. 3,046,127 and 2,951,758), combinations of triarylimidazole dimer and p-aminophenyl ketone (those described in U.S. Pat. No. 3,549,367), acrydine and phenazine compounds (those described in Japanese Laid-Open Patent Publication “Tokkai” No. S60-105667 and U.S. Pat. No. 4,239,850), and oxadiazole compounds (those described in U.S. Pat. No. 4,212,970).

An amount of the photo-polymerization initiator is preferably from 0.1 to 20% by mass, more preferably from 1 to 8% by mass, with respect to the liquid crystal composition (the solid content when the composition is a coating liquid).

(4) Alignment Controlling Agent

Any alignment controlling agent, which can contribute to stably or promptly forming a liquid crystal phase such as a cholesteric liquid crystal phase, may be added to the liquid crystal composition of the invention. Examples of the alignment controlling agent include fluorine-containing (meth)acrylate series polymers and compounds represented by formula (X1)-(X3). Two or more types selected from these compounds may be used in combination. These compounds may contribute to aligning liquid crystal molecules with a small tilt angle or horizontally at the air-interface alignment. It is to be understood that the term “horizontal alignment” in the specification means that the direction of long axis of a liquid crystalline molecule is parallel to the layer plane, wherein strict parallelness is not always necessary; and means, in this specification, that a tilt angle of the mean direction of long axes of liquid crystalline molecules with respect to the horizontal plane is smaller than 20°. The layer in which liquid crystal molecules are horizontally aligned at the air-interface may hardly suffer from alignment defects, and may have a high transparency for a visible light and have a high reflection rate. On the other hand, the layer in which liquid crystal molecules are aligned with a large tilt angle may suffer from the finger-print pattern, and may have a low reflective rate, high haze and diffraction characteristics, because of the misalignment between the helical axis of the cholesteric liquid crystal phase and the normal line of the layer surface.

Examples of the fluorine-containing (meth)acrylate series polymer, which can be used as an alignment controlling agent, include those described in JPA 2007-272185, [0018]-[0043].

The compounds represented by formula (X1)-(X3), which can be used as an alignment controlling agent, will be described in detail respectively.

In the formula, R¹, R² and R³ each independently represent a hydrogen atom or a substituent group; X¹, X² and X³ each independently represent a single bond or divalent linking group. The substituent group represented by R¹-R³ respectively is preferably a substituted or non-substituted alkyl group (more preferably a non-substituted alkyl or a fluorinated alkyl group), an aryl group (more preferably an aryl group having at least one fluorinated alkyl group), a substituted or non-substituted amino group, an alkoxy group, an alkylthio group, or a halogen atom. The divalent linking group represented by X¹, X² and X³ respectively is preferably selected from the group consisting of an alkylene group, an alkenylene group, a divalent aryl group, a divalent heterocyclic group, —CO—, —NR^(a)— (where R^(a) represents a C₁₋₅ alkyl group or a hydrogen atom), —O—, —S—, —SO—, —SO₂— and any combinations thereof. The divalent linking group is preferably selected from the group consisting of an alkylene group, a phenylene group, —CO—, —NR^(a)—, —O—, —S—, —SO₂— and any combinations thereof. The number of carbon atom(s) in the alkylene group is preferably from 1 to 12. The number of carbon atoms in the alkenylene group is preferably from 2 to 12. The number of carbon atoms in the aryl group is preferably from 6 to 10.

In the formula, R represents a substituent group; and m is an integer of from 0 to 5. When m is equal to or more than 2, two or more R are same or different from each other. Preferable examples of the substituent group represented by R are same as those exemplified above as an example of R¹, R² or R³ in formula (X1). In the formula, m is preferably from 1 to 3, and is especially preferably 2 or 3.

In the formula, R⁴, R⁵, R⁶, R⁷, R⁸ and R⁹ each independently represent a hydrogen atom or a substituent group. Preferable examples of R⁴, R⁵, R⁶, R⁷, R⁸ or R⁹ include those exemplified above as an example of R¹, R² or R³ in formula (X1).

Examples of the compound represented by formula (X1), (X2) or (X3), which can be used as an alignment controlling agent, include the compounds described in JPA 2005-99248.

One compound of formula (X1), (X2) or (X3) may be used alone, or two or more compounds of formula (X1), (X2) or (X3) may be used in combination.

An amount of the compound represented by formula (X1), (X2) or (X3) to be added to the liquid crystal composition is preferably from 0.01 to 10% by mass, more preferably from 0.01 to 5% by mass, or especially preferably from 0.02 to 1 by mass, with respect to an amount of the liquid crystal compound.

(5) Process for Preparing Films of Composition

The composition of the invention is useful for preparing optical films such as retardation films and reflective films. One example of the process for preparing the film comprising

(i) applying the polymerizable liquid crystal composition of the invention to the surface of a substrate or the like to form a liquid crystal phase (a cholesteric liquid crystal phase); and

(ii) irradiating the curable liquid-crystal composition with ultraviolet light for promoting the curing reaction, thereby fixing the liquid crystal phase (the cholesteric liquid crystal phase) and then forming a light-reflective layer.

The steps of (i) and (ii) may be repeated to form a lamination of the plural cured films. The liquid-crystal composition is preferably prepared as a coating liquid of the material dissolved and/or dispersed in a solvent. The coating liquid may be applied to the substrate or the like, according to various methods of a wire bar coating method, an extrusion coating method, a direct gravure coating method, a reverse gravure coating method, a die coating method or the like. As the case may be, an inkjet apparatus may be used in which a liquid-crystal composition may be jetted out through a nozzle to form the intended coating film.

Next, the coating film of the liquid-crystal composition formed on the surface of the substrate or the like is made to have a liquid crystal phase such as a cholesteric liquid crystal phase. In an embodiment where the curable liquid-crystal composition is prepared as a coating liquid that contains a solvent, the coating film may be dried to remove the solvent, thereby the coating film may be made to have the intended liquid-crystal phase. If desired, the coating film may be heated up to the transition temperature to the cholesteric liquid-crystal phase. For example, the coating film is once heated up to the temperature of the isotopic phase, and then cooled to the liquid crystal phase transition temperature, whereby the film may stably have the intended liquid-crystal phase. The liquid-crystal transition temperature of the liquid crystal composition is preferably within a range of from 10 to 250 degrees Celsius from the viewpoint of the production aptitude, more preferably within a range of from 10 to 150 degrees Celsius. When the temperature is lower than 10 degrees Celsius, the coating film may require a cooling step or the like for cooling it to the temperature range within which the film could exhibit a liquid-crystal phase. On the other hand, when the temperature is higher than 250 degrees Celsius, the coating film may require a higher temperature in order that it could be in an isotropic liquid state at a higher temperature than the temperature range within which the film once exhibits a liquid-crystal phase; and this is disadvantageous from the viewpoint of heat energy dissipation, substrate deformation, degradation, etc.

Next, in the step of (ii), the coating film in a liquid crystal state is irradiated with ultraviolet light to promote the curing reaction thereof. For ultraviolet irradiation, used is a light source of an ultraviolet lamp or the like. In this step, the ultraviolet irradiation promotes the curing reaction of the liquid-crystal composition, and the liquid crystal phase is thereby fixed and the intended light-reflective layer is thus formed.

The ultraviolet irradiation energy dose is not specifically defined, but in general, it is preferably from 100 mJ/cm² to 800 mJ/cm² or so. Not specifically defined, the time for ultraviolet radiation to the coating film may be determined from the viewpoint of both the sufficient strength of the cured film and the producibility thereof.

For promoting the curing reaction, ultraviolet irradiation may be attained under heat. The temperature in ultraviolet irradiation is preferably kept within a temperature range within which the cholesteric liquid-crystal phase can be kept safely as such with no disturbance. The oxygen concentration in the atmosphere participates in the degree of polymerization of the cured film. Accordingly, in case where the cured film could not have the intended degree of polymerization in air and the film strength is therefore insufficient, preferably, the oxygen concentration in the atmosphere is lowered according to a method of nitrogen purging or the like.

In the above step, the cholesteric liquid-crystal phase is fixed and the intended light-reflective layer is thereby formed. A most typical and preferred embodiment of the “fixed” liquid-crystal state is such that the alignment of the liquid-crystal compound to form the liquid crystal phase is held as such, to which, however, the invention is not limited. Concretely, the fixed state means that, in a temperature range of generally from 0 to 50 degrees Celsius, or from −30 to 70 degrees Celsius under a severer condition, the layer does not have flowability and does not undergo any alignment morphology change in an external field or by an external force applied thereto, and the layer can continue to stably keep the fixed alignment morphology. In the invention, the alignment state of the liquid-crystal phase is fixed through the curing reaction as promoted by ultraviolet irradiation.

In the invention, it is enough that the optical properties of the liquid crystal phase are held in the layer, and finally it is any more unnecessary that the liquid-crystal composition in the cured layer exhibits liquid crystallinity. For example, the liquid-crystal composition may be converted to a high-molecular weight substance and may lose the liquid crystallinity.

The thickness of the cured layer is not limited. The preferable thickness is determined depending on its application or the desired optical properties. Usually, the thickness is preferably from 0.1 to 20 micro meters, or more preferably from 0.5 to 10 micro meters.

(6) Substrate

The film of the invention may have a substrate. The substrate may be selected from those having a self-supporting property or those capable of supporting the cured layer. The materials or optical properties thereof are not limited. In some applications, the substrate may be required to have a high transmission for a visible light. Polymer films having a high transmission for a visible light include those used in display devices such as a liquid crystal display device as an optical film. Preferable examples of the polymer film which can be used as a substrate include poly ester films such as polyethylene terephthalate (PET), polybutylene and polyethylene naphthalate (PEN) films; polycarbonate (PC) films; polymethylmethacrylate films; polyolefin films such as polyethylene and polypropylene films; polyimide films, triacetyl cellulose (TAC) films. Polyethylene terephthalate and triacetyl cellulose are preferable.

(7) Alignment Layer

The film of the invention may have an alignment layer disposed between the cured layer and the substrate. The alignment layer may have a function capable of aligning liquid crystal molecules in the cholesteric liquid crystal layer more precisely. The alignment layer may be prepared by subjecting a film made of an organic compound (preferably a polymer) to a rubbing treatment, obliquely depositing an inorganic compound, forming a layer having microgrooves. Alignment layers having an alignment effect under an electric or magnetic field or irradiation are also known. Among these, alignment layers prepared by subjecting a film of a polymer to a rubbing treatment are preferred.

Examples of the material which can be used for preparing the alignment layer include polymers such as polymethylmethacrylate, acrylic acid/methacrylic acid copolymer, styrene/maleimide copolymer, polyvinyl alcohol, modified polyvinyl alcohol, poly(N-methylolacrylamide), styrene/vinyl toluene copolymer, chloridosulfuric polyethylene, cellulose nitrate, polyvinyl chloride, chlorinated polyolefin, polyester, polyimide, vinyl acetate/vinyl chloride copolymer, ethylene/vinyl acetate copolymer, carboxymethyl cellulose, gelatin, polyethylene, polypropylene and polycarbonate; and silane coupling agents. Preferable examples of the polymer are water-soluble polymers such as poly(N-methylolacrylamide), carboxymethyl cellulose, gelatin, polyvinyl alcohol and modified polyvinyl alcohol; gelatin, polyvinyl alcohol and modified polyvinyl alcohol are more preferable; and polyvinyl alcohol and modified polyvinyl alcohol are specially preferable.

(8) Applications of Films

One embodiment of the film of the invention is a film of the cured liquid crystal alignment (for example, horizontal alignment, vertical alignment, hybrid alignment) of the polymerizable liquid crystal composition, exhibiting optical anisotropy. The film may be used as an optical compensation film for liquid crystal displaying devices.

Another embodiment of the film of the invention is a film of the cured cholesteric liquid crystal phase of the polymerizable liquid crystal composition, exhibiting selective reflection at the wavelength range. The film exhibiting selective reflection at the IR wavelength region (800-1300 nm) may be attached to window plates of buildings or vehicles or may be incorporated into laminated glasses, which may be used as a heat-shielding member.

3. Polymer

The present invention relates to polymers prepared by carrying out polymerization of one or two or more polymerizable liquid crystal compounds represented by formula (I), to polymers prepared by carrying out polymerization of the polymerizable liquid crystal composition of the invention. The polymers may exhibit liquid-crystallinity or non-liquid-crystallinity. The polymers have the repeating unit derived from the polymerizable liquid crystal compound represented by formula (I), may exhibit high Δn, and may be useful as a material of various optical elements.

EXAMPLES

Paragraphs below will further specifically describe features of the present invention, referring to Examples and Comparative Examples. Any materials, amount of use, ratio, details of processing, procedures of processing and so forth shown in Examples may appropriately be modified without departing from the spirit of the present invention. Therefore, it is to be understood that the scope of the present invention should not be interpreted in a limited manner based on the specific examples shown below.

Example 1 Synthetic Example of Compound G-2

Compound G-2 was prepared according to the following scheme.

Synthesis of Compound G-2A:

Hydrazine monohydrate (2.8 mL) was added to a methanol solution (100 mL) of 4-hydroxypropiophenone (18 g), and after adding with acetic acid (0.4 mL) as a catalyst, was refluxed under heat for three hours. The reaction liquid was cooled to a room temperature, and then the generated crystals were filtered to give 14.4 g of Compound G-3A (yield 87%). The determination of the obtained compound was performed by measurement of ¹H-NMR spectra.

¹H-NMR (400 MHz, DMSO-d6): δ1.0 (t, 6H), δ2.8 (q, 4H), δ6.85 (d, 4H), δ7.8 (d, 4H), δ9.85 (bd, 2H).

Synthesis of Compound G-2:

4-(4-acryloyloxybutyloxy) cinnamic acid was prepared according to the process described in Japanese Patent No. 4355406, p. 23, [0109]-[0110].

Methane sulfonyl chloride (3.34 mL) and 4-(4-acryloyloxybutyloxy) cinnamic acid (12.65 g) were stirred in tetrahydrofuran (50 mL), and added dropwise with di-isopropyl ethylamine (8.35 mL) while the inner temperature was kept at a temperature of equal to or lower than 0 degree Celsius. The mixture was stirred for an hour at the same temperature, added with Compound G-2A (6.33 g), and then added dropwise with di-isopropyl ethylamine (8.35 mL) while the inner temperature was kept at a temperature of equal to or lower than 5 degrees Celsius. After the dropwise addition, p-methoxy phenol (0.1 g) was added to the mixture, and was stirred for three hours at a room temperature. The reaction liquid was added with ethyl acetate (80 mL) and water (80 mL), and then the solvent was removed from the reaction liquid by distillation under a reduced pressure. Ethyl acetate (10 mL) and methanol (100 mL) were added to the concentrated material, refluxed under heat for 30 minutes, and cooled to a room temperature. The crystals were filtered to give 12.0 g of Compound G-2 (yield 66%). The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ1.15 (t, 6H), δ1.9-1.95 (m, 8H), δ2.9 (q, 4H), δ4.05-4.1 (m, 4H), δ4.15-4.2 (m, 4H), δ5.85 (d, 2H), δ6.15 (dd, 2H), δ6.4 (d, 2H), δ6.5 (d, 2H), δ6.9 (d, 4H), δ7.2 (d, 4H), δ7.55 (d, 4H), δ7.85 (d, 2H), 7.95 (d, 4H).

Example 2 Synthetic Example of Compound G-3

Compound G-3 was prepared according to the following scheme.

Synthesis of Compound G-3A:

Compound G-3A (yield 82%) was prepared in the same manner as In the process of preparing Compound G-2A, except that an equivalent mole of 4-hydroxy-3-methoxy-acetophenone was used in place of 4-hydroxy propiophenone. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ2.3 (s, 6H), δ4.0 (s, 6H), δ5.8 (s, 2H), δ6.95 (d, 2H), δ7.3 (d, 2H), δ7.65 (s, 2H).

Synthesis of G-3:

Compound G-3 (yield 78%) was prepared in the same manner as the process of preparing Compound G-2, except that an equivalent mole of G-3A was used in place of a material, G-2A. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHZ, CDCL₃): Δ1.9-2.0 (M, 8H), Δ2.3 (S, 6H), Δ3.9 (S, 6H), Δ4.1-4.15 (M, 4H), Δ4.25-4.3 (M, 4H), Δ5.85 (D, 2H), Δ6.15 (DD, 2H), Δ6.4 (D, 2H), Δ6.5 (D, 2H), 7.0 (D, 4H), Δ7.2 (D, 2H), Δ7.4 (D, 2H), Δ7.7 (S, 2H), 7.9 (D, 4H).

Example 3 Synthetic Example of Compound G-6

Compound G-6 was prepared according to the following scheme.

Synthesis of G-B:

Compound G-B was prepared in the same manner as the method described in Japanese Patent No. 4355406, p. 23, [109]-[110], except that cyanoacetic acid was used in place of malonic acid. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ1.85-2.0 (m, 4H), δ4.1-4.15 (m, 2H), δ4.25-4.3 (m, 2H), δ5.85 (d, 1H), δ6.15 (dd, 1H), δ6.4 (d, 1H), δ7.0 (d, 2H), δ8.0 (d, 2H), 8.25 (s, 1H).

Synthesis of Compound G-6:

Methane sulfonyl chloride (0.59 mL) and Compound G-B (2.39 g) were stirred in tetrahydrofuran (10 mL), and added dropwise with di-isopropyl ethylamine (1.47 mL) while the inner temperature was kept at a temperature of equal to or lower than 0 degree Celsius. The mixture was stirred for an hour at the same temperature, added with Compound G-3A (1.19 g), and then added dropwise with di-isopropyl ethylamine (1.47 mL) while the inner temperature was kept at a temperature of equal to or lower than 5 degrees Celsius. After the dropwise addition, p-methoxy phenol (0.05 g) was added to the mixture, and was stirred for 30 three hours at a room temperature. The reaction liquid was added with methanol (100 mL), and then the crystals were filtered. The obtained crystals were added with ethyl acetate (10 mL) and p-methoxyphenol (0.05 g), refluxed under heat for 30 minutes, and cooled to a room temperature. The crystals were filtered to give 2.2 g of Compound G-6 (yield 62%). The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ1.9-2.0 (m, 8H), δ2.3 (s, 6H), δ3.9 (s, 6H), δ4.1-4.15 (m, 4H), δ4.25-4.3 (m, 4H), δ5.85 (d, 2H), δ6.15 (dd, 2H), δ6.4 (d, 2H), δ7.0 (d, 4H), δ7.2 (d, 2H), δ7.45 (d, 2H), δ7.7 (s, 2H), δ8.1 (d, 4H), δ8.35 (s, 2H).

Example 4 Synthetic Example of Compound G-4

Compound G-4 was prepared according to the following scheme.

Synthesis of Compound G-4A:

Compound G-4A (yield 80%) was prepared in the same manner as the process of preparing Compound G-2A, except that an equivalent mole of 4-hydroxyacetophenone was used in place of a material, 4-hydroxypropiophenone. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, DMSO-d6): δ2.25 (s, 6H), δ6.95 (d, 4H), δ7.8 (d, 4H), δ9.85 (bd, 2H).

Synthesis of Compound G-4:

Compound G-4 (yield 60%) was prepared in the same manner as the method of preparing Compound G-6, except that an equivalent mole of G-4A was uses in place of a material, G-3A. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ1.85-2.0 (m, 8H), δ2.35 (s, 6H), δ4.1-4.15 (m, 4H), δ4.25-4.3 (m, 4H), δ5.85 (d, 2H), δ6.15 (dd, 2H), δ6.4 (d, 2H), δ7.0 (d, 4H), δ7.3 (d, 4H), δ8.0 (d, 4H), δ8.1 (d, 4H), 8.3 (s, 2H).

Example 5 Synthetic Example of Compound G-5

Compound G-5 was prepared according to the following scheme.

Synthesis of Compound G-5

Compound G-5 (yield 68%) was prepared in the same manner as the process of preparing Compound G-6, except that an equivalent mole of G-2A was used in place of a material, G-3A. The determination of the obtained compound was performed by measurement of ¹H-NMR.

¹H-NMR (400 MHz, CDCl₃): δ1.15 (t, 6H), δ1.85-2.0 (m, 8H), δ2.9 (q, 4H), δ4.1-4.15 (m, 4H), δ4.25-4.3 (m, 4H), δ5.85 (d, 2H), δ6.15 (dd, 2H), δ6.4 (d, 2H), δ7.0 (d, 4H), δ7.3 (d, 4H), δ8.0 (d, 4H), δ8.1 (d, 4H), 8.3 (s, 2H).

Example 6 Preparation of Retardation Film

A liquid crystal composition having the following formulation was prepared by using Compound G-2, which was prepared in the above-described example. This was used as Coating Liquid (1).

Compound (G-2) 33 parts by mass Polymerizable liquid crystal compound (M-1) 67 parts by mass Agent for controlling alignment at an air-interface (1) 0.1 part by mass Polymerization initiator IRGACURE819 (Ciba-Japan) 3 parts by mass Solvent chloroform 800 parts by mass Polymerizable liquid crystal compound (M-1)

Agent for controlling alignment at an air-interface (1)

A glass substrate was washed and dried, a commercially-available polyimide alignment film (SE-130, from Nissan Chemical Industries, Ltd.) was formed according to a coating method using a wire bar, the coated film was heated at 250 degrees Celsius for one hour, allowed to cool, and rubbed at room temperature. Coating liquid (1) was applied to the surface of the alignment film according to a spin coating method at a room temperature. The coated film was heated at 120 degrees Celsius for 30 minutes for maturation, and then irradiated with UV light under an atmosphere of nitrogen gas at a room temperature for 10 seconds by a high-pressure mercury lamp without shorter wavelength components, thereby to fix the alignment and form a retardation film, Retardation film 1. During the period from the step of applying the coating liquid to the step of heating it, any precipitated crystals were not found.

Retardation film 1 was observed under a polarizing microscope, and the monoaxial alignment without any alignment defect was found in the film. The film was measured in a Tip-Tilt mode by using AxoScan manufactured by AXOMETRIX. The averaged tilt angle calculated by AxoScan was 1 degree, and it was confirmed that an A-plate type retardation film was obtained. The value of Δn at a wavelength of 550 nm was 0.235, which was calculated on the basis of retardation, measured by AxoScan, and the thickness of the retardation film, measured by a confocal scanning laser thickness-measuring equipment, “FV-750”, manufactured by KEYENCE.

Examples 7-10

Each of Liquid crystal compositions, Coating liquids (2)-(5), was prepared in the same manner as Example 6, except that each of the compounds prepared in the above examples was used in place of Compound G-2. Each of Retardation films 2-5 was prepared in the same manner as Example 6, except that the polymerization temperature was changed to 100 degrees Celsius when Compound G-4 or G-5 was used. All of the obtained retardation films showed a good alignment-property, and had a haze value of 0.1 or lower. The Δn values at 550 nm of the retardation films, which were calculated in the same manner as described above, are shown in Table 1.

Comparative Example 1 Formation of Comparative Retardation Film

A liquid crystal composition, having the following formulation, Coating liquid (11), was prepared in the same manner as Example 6.

Polymerizable liquid crystal compound (M-1) 100 parts by mass Agent for controlling alignment at an air- 0.1 part by mass interface (1) Polymerization initiator IRGACURE819 3 parts by mass (Ciba-Japan) Solvent chloroform 800 parts by mass

Retardation film 6 was prepared in the same manner as Example 6, except that Coating liquid (11) was used in place of Coating liquid (1). And the upper limit of the temperature at which the liquid crystal composition of Coating liquid (11) showed the liquid crystal phase was lower than that of Example 1, the maturing temperature was changed to 90 degrees Celsius. During the period from the step of applying the coating liquid to the step of heating it, some precipitated crystals were found. As a result, after maturing the alignment by heating again, unevenness in the thickness remained at the part of precipitation. The haze value of the film was 0.19. The Δn value at 550 nm of Retardation film 6, which was calculated in the same manner as described above, was 0.170.

Comparative Example 2 Formation of Comparative Retardation Film

Coating liquid (12) was prepared in the same manner as Example 6, except that Compound M-2 was used in place of Compound G-2. Retardation film 7 was prepared in the same manner as Example 6, except that Coating liquid (12) was used in place of Coating liquid (1). And the upper limit of the temperature at which the liquid crystal composition of Coating liquid (12) showed the liquid crystal phase was lower than that of Example 1, the maturing temperature was changed to 100 degrees Celsius. The obtained retardation film showed a good alignment-property, and had a haze value of 0.1 or lower. The Δn value at 550 nm of Retardation film 7, which was calculated in the same manner as described above, was 0.195.

The results are shown in the following table.

TABLE 1 Compound Δn Haze Example 6 G-2 0.235 0.09 Example 7 G-3 0.215 0.07 Example 8 G-4 0.225 0.08 Example 9 G-5 0.211 0.08 Example 10 G-6 0.222 0.08 Comparative M-1 0.170 0.19 Example 1 Comparative M-2 0.195 0.11 Example 2

Example 11 Formation of Selective Reflection Film

A liquid crystal composition having the following formulation was prepared by using Compound G-2, which was prepared in the above-described example. This was used as Coating Liquid (6).

Compound (G-2) 40 parts by mass Polymerizable liquid crystal compound (M-1) 60 parts by mass Chiral agent Paliocolor LC756 (BASF) 3.2 parts by mass Agent for controlling alignment at an air- 0.04 part by mass interface (1) Polymerization initiator IRGACURE819 3 parts by mass (Ciba-Japan) Solvent chloroform 300 parts by mass

A substrate having an alignment layer thereon was prepared in the same manner as Example 6, and Coating liquid (6) was applied to the surface of the alignment layer at a room temperature according to a spin-coating method, heated at 120 degrees Celsius for three minutes for maturation, and then irradiated with UV light for 10 seconds at a room temperature by a high-pressure mercury lamp without shorter wavelength components, thereby to fix the alignment and form a selective reflection film, Selective reflection film 1. During the period from the step of applying the coating liquid to the step of heating it, any precipitated crystals were not found.

Selective reflection film 1 was observed under a polarizing microscope, and the uniform alignment without any alignment defect was found in the film. The transmission spectrum of the film was measured by using spectral photometer “UV-3100PC” (Shimadzu Corporation), and it was found that the film had a peak of selective reflection at 1000 nm of which half bandwidth was 151 nm. The Δn of the film which was calculated on the basis of the half bandwidth of the peak and the helical pitch of the liquid crystal composition was 0.239. The haze value of the film was measured by using a Haze meter “NHD2000” (NIPPON DENSHOKU INDUSTRIES CO., LTD.), and it was found that the haze value of the film was 0.12.

Examples 12-15

Liquid crystal compositions, Coating liquids (7)-(10), were prepared in the same manner as Example 11, except that the compounds prepared in Examples 2-5 were respectively used in place of Compound G-2. Selective reflection films 2-5 were respectively prepared in the same manner as Example 11, except that each of Coating liquids (7)-(10) was used in place of Coating liquid (6), and the polymerization temperature was changed to 100 degrees Celsius when Compound G-4 or G-5 was used. All of the obtained selective reflection films showed a good alignment-property, and had a haze value of 0.15 or lower. The Δn value and the half bandwidth of the peak of each of the films are shown in Table 2.

Comparative Example 3 Formation of Selective Reflection Film

A liquid crystal composition, Coating liquid (13), having the following formulation was prepared in the same manner as Example 10.

Polymerizable liquid crystal compound (M-1) 100 parts by mass Chiral agent Paliocolor LC756 (BASF) 2.8 parts by mass Agent for controlling alignment at an air- 0.04 part by mass interface (1) Polymerization Initiator IRGACURE819 3 parts by mass (Ciba-Japan) Solvent Chloroform 300 parts by mass

Selective reflection film 6 was prepared in the same manner as Example 6, except that Coating liquid (13) was used in place of Coating liquid (6). And the upper limit of the temperature at which the liquid crystal composition of Coating liquid (13) showed the liquid crystal phase was lower than that of Example 6, the maturing temperature was changed to 100 degrees Celsius. During the period from the step of applying the coating liquid to the step of heating it, some precipitated crystals were found. As a result, after maturing the alignment by heating again, unevenness in the thickness remained at the part of precipitation.

The film had a peak of selective reflection at 1000 nm of which half bandwidth was 106 nm. The Δn of the film which was calculated on the basis of the half bandwidth of the peak and the helical pitch of the liquid crystal composition was 0.168. The haze value of the film was measured by using a Haze meter “NHD2000” (NIPPON DENSHOKU INDUSTRIES CO., LTD.), and it was found that the haze value of the film was 0.88.

The results are shown in the following table.

TABLE 2 Half Compound Bandwidth Δn Haze Example 11 G-2 151 nm 0.239 0.12 Example 12 G-3 141 nm 0.222 0.09 Example 13 G-4 142 nm 0.225 0.07 Example 14 G-5 135 nm 0.213 0.05 Example 15 G-6 141 nm 0.223 0.07 Comparative M-1 106 nm 0.168 0.88 Example 3 

1. A polymerizable liquid crystal compound represented by formula (I):

where R⁰ and R¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent; L⁰ and L¹ each independently represent a hydrogen atom, or C₁₋₄ alkyl group which may have at least one substituent; A⁰ and A¹ each independently represent a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent; B⁰ and B¹ each independently represent a single bond or a divalent linking group having a 5- to 12-membered cyclic structure which may have at least one substituent; D⁰ and D¹ each independently represent —O—, —S—, or —NR²— where R² represents a hydrogen atom or C₁₋₃ alkyl group; X⁰ and X¹ each independently represent a hydrogen atom, acyl group or cyano; Y⁰ and Y¹ each independently represent a single bond, —O—, —S—, —OCO—, —COO—, —OCOO—, —NR³CO—, —CONR³—, —OCONR³—, —NR³COO—, —NR³CONR³—, —C═N— or —N═C— where R³ represents a hydrogen atom or C₁₋₃ alkyl group; Q⁰ and Q¹ each independently represent a C₁₋₂₀ divalent aliphatic group which may have at least one substituent; provided that one —CH₂— or two or more —CH₂—, which may be not adjacent to each other, may be replaced with —O—, —S—, —NR⁴—, —OCO—, —COO—, —OCOO—, —NR⁴CO—, or —CONR⁴—; R⁴ represents a hydrogen atom or C₁₋₃ alkyl group; Z⁰ and Z¹ each independently represent a hydrogen atom, cyano, halogen atom or polymerizable group; and n and m each independently represent an integer of from 0 to
 2. 2. The polymerizable liquid crystal compound of claim 1, wherein A⁰ and A¹ each independently represent a divalent aromatic group which may have at least one substituent.
 3. The polymerizable liquid crystal compound of claim 1, wherein B⁰ and B¹ each independently represent a divalent aromatic group which may have at least one substituent.
 4. The polymerizable liquid crystal compound of claim 1, wherein at least one of Z⁰ and Z¹ represents a polymerizable group selected from Group (II) shown below:


5. The polymerizable liquid crystal compound of claim 4, wherein Z⁰ and Z¹ each independently represent a polymerizable group selected from Group (II).
 6. The polymerizable liquid crystal compound of claim 1, wherein Z⁰ and Z¹ each independently represent a (meth)acrylate group.
 7. The polymerizable liquid crystal compound of claim 1, wherein n and m are
 1. 8. The polymerizable liquid crystal compound of claim 1, wherein D⁰ and D¹ are —O—.
 9. The polymerizable liquid crystal compound of claim 1, wherein L⁰ and L¹ are hydrogen atoms.
 10. The polymerizable liquid crystal compound of claim 1, wherein X⁰ and X¹ are same, and represent a hydrogen atom or cyano.
 11. The polymerizable liquid crystal compound of claim 1, wherein Y⁰ and Y¹ are —O—.
 12. The polymerizable liquid crystal compound of claim 1, wherein at least one of R⁰ and R¹ is not a hydrogen atom.
 13. A polymerizable liquid crystal composition comprising at least one polymerizable liquid crystal compound of claim
 1. 14. The polymerizable liquid crystal composition of claim 13, comprising at least one chiral compound.
 15. A polymer prepared by polymerizing a polymerizable liquid crystal compound of claim
 1. 16. A polymer prepared by polymerizing a polymerizable liquid crystal composition of claim
 13. 17. A film formed by curing a polymerizable liquid crystal composition of claim
 13. 18. A film formed by curing a cholesteric liquid crystal phase of a polymerizable liquid crystal composition of claim
 14. 19. The film of claim 17, having optical anisotropy.
 20. The film of claim 17, having selective reflection.
 21. The film of claim 17, having selective reflection in the infrared region. 